4:01 PM ET
8-K
Shareholder Meeting
Inhibitor Therapeutics Shareholder Meeting
Inhibitor Therapeutics held its 2026 Annual Meeting of Stockholders on September 15, 2026, where shareholders elected six directors to the board for one-year terms. Stockholders also ratified Cherry Bekaert LLP as the independent auditor, approved the 2025 Share Incentive Plan, and approved executive compensation on an advisory basis.